Get started
Author

Maria Hurcikova

Observed name: Hurcikova Maria
ORCID: 0009-0000-1741-5067
Observed ORCID: 0009-0000-1741-5067
OpenAlex ID: A5043321606
Faricimab Treat-and-Extend for Diabetic Macular Edema
2023 · Tien Y. Wong, Zdenka Haskova, et al. · Ophthalmology · 198
PDF
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial
2023 · Masahiko Shimura, Shigehiko Kitano, et al. · Japanese Journal of Ophthalmology · 23
PDF
Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy: Post Hoc Analysis of the PULSAR Randomized Clinical Trial
2025 · Won Ki Lee, Tien Y. Wong, et al. · JAMA Ophthalmology · 15
STudy of Atropine to Reduce (STAR) Myopia Progression in Children: 24-Month Results of a Randomized, Double-Masked, Vehicle-Controlled Trial of Atropine Sulfate 0.01% and 0.03%
2026 · Michael Korenfeld, Maria Hurcikova, et al. · Ophthalmology and Therapy · 8
PDF
PULSAR: Clinical Outcomes of Aflibercept 8 mg with Extended Dosing and 2 mg in Neovascular Age-Related Macular Degeneration in Subgroups Defined by Baseline Characteristics
2026 · Richard P. Gale, Anat Loewenstein, et al. · Ophthalmology Retina · 2
Economic Burden of Age-Related Macular Degeneration and Diabetic Macular Edema in Slovakia: a Cost-of-illness Analysis
2025 · Ladislav Janco, Jana Stefanickova, et al. · Bratislavské lekárske listy/Bratislava medical journal · 1
PDF
Correction: STudy of Atropine to Reduce (STAR) Myopia Progression in Children: 24-Month Results of a Randomized, Double-Masked, Vehicle-Controlled Trial of Atropine Sulfate 0.01% and 0.03%
2026 · Michael Korenfeld, Maria Hurcikova, et al. · Ophthalmology and Therapy
PDF
Effect of Key Baseline Disease Characteristics on Aflibercept 8 mg Dosing Interval Extension
2026 · Justus G. Garweg, Varun Chaudhary, et al. · Ophthalmology Retina
Infographic: Efficacy and Safety of High-Dose Intravitreal Aflibercept 8 mg in Patients with Treatment-Naïve Neovascular Age-Related Macular Degeneration: Week 96 Results from the Phase 3 PULSAR Trial
2026 · Jean-François Korobelnik, Sergio Leal, et al. · Eye
Author Correction: Economic Burden of Age-Related Macular Degeneration and Diabetic Macular Edema in Slovakia: a Cost-of-illness Analysis
2025 · Ladislav Janco, Jana Stefanickova, et al. · Bratislavské lekárske listy/Bratislava medical journal
PDF
Works count: 10
Citation count: 247
H-index: 4
I10-index: 3
Year
Topic
Type